Crinetics Pharmaceuticals, Inc. (CRNX)
38.23
-0.67
(-1.72%)
USD |
NASDAQ |
Mar 06, 16:00
38.29
+0.06
(+0.16%)
After-Hours: 05:08
Crinetics Pharmaceuticals SG&A Expense (TTM) : 191.33M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 11.09M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| GT Biopharma, Inc. | 4.731M |
| Axsome Therapeutics, Inc. | 570.60M |
| Sutro Biopharma, Inc. | 41.39M |